Abivax enrols first participant in Phase IIb Crohn’s disease drug trial
Abivax has enrolled the first subject in the Phase IIb ENHANCE-CD clinical trial of its lead investigational drug candidate obefazimod …
Post
-
-
Summit completes subject enrolment in Phase III NSCLC treatment trial
Summit Therapeutics has concluded subject enrolment in the Phase III HARMONi clinical trial of ivonescimab, along with platinum-doublet chemotherapy for …
-
Cloud-Based Clinical Trials Solutions & Companies
Cloud-based clinical trials can reduce the huge expense and long lead times of traditional clinical trials. Clinical data sharing improves …
-
Women are dying unnecessarily due to the underdiagnosis of heart disease
In the UK, heart disease is the leading cause of death in women. As heart disease is historically more prevalent …
-
Clinical Trial Data Management Companies for the Clinical Trials Industry
Clinical trial data management involves gathering, refining and managing the data of an individual, according to regulatory requirements. It supports …
-
Clinical Development Services, Solutions & Companies in Clinical Research
Clinical trials enable pharmaceutical, biopharmaceutical, life sciences and medical device companies to advance their discoveries into novel treatments and licensed …
-
Bioavailability Studies and Bioequivalence Services for the Clinical Trials Industry
Bioavailability studies are performed to determine the movement of an active ingredient through the system into the systemic circulation and …
-
Processa Pharmaceuticals doses first subject in Phase II breast cancer trial
Processa Pharmaceuticals has dosed the first subject in its Phase II clinical trial of Next Generation Capecitabine (NGC-Cap) to treat …
-
NIH selects Emergex’s T cell vaccine for trials under Project NextGen
The National Institutes of Health (NIH) unit of the National Institute of Allergy and Infectious Diseases (NIAID) has selected Emergex …
-
Qnovia set to trial smoking cessation inhaler in the US
Qnovia has received clearance from the US Food and Drug Administration (FDA) to start a clinical trial for its RespiRX …
-
SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study
SetPoint Medical has been given an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) greenlighting it …
-
Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess the combination of casdatifan (AB521) and volrustomig in …
-
UroGen begins subject dosing in Phase III bladder cancer drug trial
UroGen Pharma has announced the dosing of the first subject in the Phase III UTOPIA clinical trial of its investigational …
-
Biostatistics Consulting: Biostatistics Outsourcing Services & Companies in Clinical Research
Biostatistics has found applications in several clinical research fields such as clinical studies, epidemiology, population genetics, and systems biology. Thus, …
-
Exscientia outline robot and AI use in drug discovery workflow
As AI continues to disrupt the healthcare industry, more pharma companies are using algorithms to design drug molecules. AI-driven pharma tech …
